Chemoresistant HSC-like cells in non-CR AML were found to express more LSC markers, including CD9, CD82, CD123 (IL3RA), and IL1RAP than those from CR AML (Figure 2F) (41). This evidence concerns the gene CD9 and acute myeloid leukemia.